Of note, although GDF15 effects on body weight were only partial, the improvements in glucose disposal and hepatic steatosis observed in OPA1 BKO mice were completely abolished in the absence of BAT GDF15, highlighting additional mechanisms of GDF15-mediated metabolic protection that are independent of its body weight-lowering effects. This evidence concerns the gene OPA1 and fatty liver disease.